## Organophosphate Poisoning: Muscarinic Symptom Management ### Mechanism of Organophosphate Toxicity Organophosphates irreversibly inhibit acetylcholinesterase, causing accumulation of acetylcholine at both nicotinic and muscarinic receptors. This produces the classic **SLUDGE syndrome**: Salivation, Lacrimation, Urination, Defecation, GI upset, Emesis — all muscarinic manifestations. ### Why Atropine Is First-Line **Key Point:** Atropine is a competitive muscarinic antagonist that rapidly reverses muscarinic symptoms (salivation, bronchospasm, bradycardia, miosis) by blocking acetylcholine at M1–M3 receptors. **High-Yield:** Atropine does NOT reverse nicotinic symptoms (muscle fasciculations, weakness, paralysis) — these require pralidoxime. **Clinical Pearl:** Atropine is given in **large, repeated doses** (2–5 mg IV bolus, repeated every 5–10 minutes) until signs of atropinization appear (dry mouth, dilated pupils, tachycardia). Titrate to drying of secretions, not full pupil dilation. ### Two-Drug Approach in Organophosphate Poisoning | Drug | Mechanism | Target Symptoms | Timing | |------|-----------|-----------------|--------| | **Atropine** | Muscarinic antagonist | SLUDGE (salivation, bronchospasm, bradycardia, miosis) | Immediate; repeat frequently | | **Pralidoxime** | Reactivates AChE (if given early) | Nicotinic (fasciculations, weakness, paralysis) | Within 24–48 hrs of exposure | **Mnemonic:** **SLUDGE = Muscarinic** → **Atropine**; **Fasciculations = Nicotinic** → **Pralidoxime** ### Why Atropine First? 1. Life-threatening muscarinic effects (bronchospasm, pulmonary edema, bradycardia) occur immediately. 2. Atropine is rapidly effective and reversible. 3. Pralidoxime takes 30–60 minutes to work and is less effective if given late (after "aging" of the phosphorylated enzyme). **Key Point:** Both drugs are used together in moderate-to-severe poisoning, but atropine is the immediate, life-saving intervention.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.